A Multicenter Phase II Study Evaluating Fludarabine, Cyclophosphamide, and Subcutaneous Campath (FCCAM) for Previously Untreated Chronic Lymphocytic Leukemia

Authors
Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: f9addb4249882b36f9733ebcef1e0bafdc0dbae5
First added on: Feb 19, 2025